Researchers analyzed airway and blood samples from children with respiratory syncytial virus (RSV). They discovered elevated ...

Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer cell ...

The TIMING™ platform, supported by AI, enables advanced label-free cell analysis for cancer immunotherapy. By observing ...

The CDC recommends most adults log at least seven hours of sleep per night, putting emotional well-being at the top of the ...

ILT: Immunoglobulin-like transcript; KIR: Killer cell immunoglobulin-like receptor; LIR: Leukocyte immunoglobulin-like receptor; MIC: MHC class I-like; NKR: Natural killer cell receptor ...

Researchers from Brigham and Women’s Hospital published new research in Science Translational Medicine showing that natural ...

PH-894: Potent and Specific Silencing of BRD4 in NK CellsMarlborough, Massachusetts--( - October 16, 2024) - Phio ...

Trinity College Dublin researchers, based at St James's Hospital have provided important insights into the behavior and metabolic function of a previously largely unknown, but crucial 'natural killer' ...

Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing placental-derived technologies, today announced that it has received a formal notice from ...

Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of placental-derived advanced biomaterial ...

CytoMed Therapeutics (NASDAQ:GDTC – Get Free Report)‘s stock had its “speculative buy” rating reaffirmed by equities researchers at Benchmark in a research report issued on Thursday, Benzinga reports.